QC
ACH

Quantedge Capital’s Accendra Health ACH Stock Holding History

Quantedge Capital’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-19,300
Closed -$261K – 214
2024
Q2 		$261K Buy
+19,300
New +$395K 0.09% 153

Other funds holding ACH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Quantedge Capital's ACH Position: Q3 2024 in Review

Quantedge Capital sold out of Accendra Health (ACH) in Q3 2024, closing a stake of 19,300 shares — an estimated $261K sold.

Quantedge Capital first reported a position in ACH in Q2 2024 and held it in 1 quarter. The position peaked at $261K in Q2 2024. 214 funds tracked by Wall St. Rank hold ACH as of Q3 2024.

  • Quantedge Capital reported no remaining Accendra Health position as of Q3 2024 after selling out during the quarter.
  • Quantedge Capital sold 19,300 Accendra Health shares in Q3 2024, an estimated $261K.
  • Quantedge Capital first reported a position in Accendra Health in Q2 2024 and held it in 1 quarter.
  • Quantedge Capital's Accendra Health position peaked at $261K in Q2 2024.
  • 214 funds tracked by Wall St. Rank held Accendra Health as of Q3 2024.

Based on Quantedge Capital's 13F filing for Q3 2024, filed 13 Nov 2024.